| mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.0062 |
0.8 |
| mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
| mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
0.0065 |
0.8 |
| mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |